Rare Syndromes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rare syndromes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rare Syndromes Today - Breaking & Trending Today

UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting -April 12, 2024 at 01:05 am EDT

UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting

Diverse and. ....

Bruxelles Capitale , United States , Laurent Schots , Daphne Teo , Nick Francis , Donatello Crocetta , Becky Malone , Jim Baxter , Antje Witte , Mike Davis , Corporate Communications , Global Communications , Group Of Companies , American Academy Of Neurology , Ucb Inc , Advisory Committee On Immunization Practices , Alexza Pharmaceuticals Inc , Rare Syndromes Communications , Program See Boxed Warning , Rare Disease Communications , Global Rare Disease Communications , Euronext Brussels , American Academy , Annual Meeting , Myasthenia Gravis , Seizure Termination ,

UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting

Study presents new persistence analysis of FINTEPLA, evaluating the efficacy and tolerability of FINTEPLA over a span of 12 months1 Real-world data looks into the need for resources to support caregivers – both parents and siblings – of people living with developmental and epileptic encephalopathies such as Dravet and Lennox-Gastaut syndromes in the transition from […] ....

United States , Bruxelles Capitale , Becky Malone , Lauried Bailey , Tom Stanton , Brad Chapman , Antje Witte , Rare Epilepsy Parents , A Survey Of Rare Epilepsy Parents , Program See Boxed Warning , Guideline Development , Group Of Companies , Epilepsy Foundation , Corporate Communications , Child Neurology Foundation , Bull World Health Organ , Ucb Inc , American Epilepsy Society Annual Meeting , Danny Did Foundation , American Epilepsy Society , Annual Meeting , Rare Syndromes , Month Persistence Analysis , Dravet Syndrome , Komodo Healthcare , Adult Siblings ,

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

UCB will present 29 abstracts, including 4 late breakers, at American Epilepsy Society Annual Meeting 2023 highlighting clinical, health economic and. ....

United States , With Of , Region Flamande , Bruxelles Capitale , Mike Davis , Jacobs Le Van , Lacosamide Monotherapy , Antje Witte , Brad Chapman , Becky Malone , Alexza Pharmaceuticals Inc , Corporate Communications , Subgroup Data From The International , American Epilepsy Society Annual Meeting , Program See Boxed Warning , Community Pharmacist , American Epilepsy Society , A Survey Of Rare Epilepsy Parents , Findings From , Ucb Inc , Group Of Companies , Global Head , Rare Syndromes , Sudden Unexpected Death , Seizure Termination , Beyond Seizures ,

NAYZILAM® (midazolam) Results Published in 'Epilepsy & Behavior' Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters

Median time to return to full baseline function occurred within 90 minutes following outpatient treatment with NAYZILAM® (midazolam) nasal spray, with a. ....

Bruxelles Capitale , Becky Malone , Brad Chapman , Antje Witte , Us Communications , Drug Administration , Epilepsy Foundation , Bull World Health Organ , Group Of Companies , Ucb Inc , Rare Syndromes , Safety Information , Concomitant Use , Prescribing Information , Euronext Brussels , World Health , Who Can Get , Pharmaceuticals , Medical Pharmaceuticals , Health Care Amp Hospitals , Olls And Research ,

UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio

UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio ....

United Kingdom , Bruxelles Capitale , City Of , Orrin Devinsky , Encephalopathies Dees , Helen Cross , Mike Davis , Institute Of Child Health , European Society Of Cardiology , Langone Health Comprehensive Epilepsy Center , International Epilepsy Congress , European Respiratory Society , Seizure Termination Project , Rapid Early Seizure Termination , Global Epilepsy , Rare Syndromes , Epileptic Encephalopathies , Professor Helen Cross , Childhood Epilepsy , Ormond Street Institute , Child Health , Young Epilepsy , Sudden Unexpected Death , Comprehensive Epilepsy Center , Early Seizure , Seizure Termination ,